Avience Biomedicals IPO Live GMP Today
As of 24 Jun 2026, 08:55 pm IST, Avience Biomedicals SME IPO is quoting a grey market premium of +₹107 (+51.4% over the issue price), implying a listing around ₹315 per share.
| Status | Listed |
| Type | SME |
| Open Date | Jun 18, 2026 |
| Close Date | Jun 22, 2026 |
| Listing Date | Jun 25, 2026 |
| Lot Size | 1200 shares |
| Issue Size | ₹30.24 Cr |
| Date | GMP (Rs) | Change | GMP % | Est. Listing |
|---|---|---|---|---|
| Jun 24, 2026 08:55 pm | +107 | ▲ 12 | +51.4% | ₹315 |
| Jun 24, 2026 04:48 pm | +95 | ▲ 12 | +45.7% | ₹303 |
| Jun 23, 2026 07:52 pm | +83 | ▲ 10 | +39.9% | ₹291 |
| Jun 22, 2026 05:34 pm | +73 | ▼ 12 | +35.1% | ₹281 |
| Jun 19, 2026 04:38 pm | +85 | ▲ 10 | +40.9% | ₹293 |
| Jun 18, 2026 08:37 am | +75 | ▲ 1 | +36.1% | ₹283 |
| Jun 17, 2026 01:55 pm | +74 | ▲ 11 | +35.6% | ₹282 |
| Jun 17, 2026 06:34 am | +63 | ▼ 7 | +30.3% | ₹271 |
| Jun 16, 2026 11:58 am | +70 | — | +33.7% | ₹278 |
Avience Biomedicals IPO GMP — Detailed Analysis
What Avience Biomedicals GMP Tells Us Today
The current Grey Market Premium for Avience Biomedicals IPO is Rs 107 (51.4% over the issue price). Based on this GMP, the implied listing price hovers around Rs 315 per share. Across the 9 GMP records captured for this issue, the trend has been rising by Rs 37 — a useful directional signal for gauging investor sentiment as the listing date approaches.
How to Read the Avience Biomedicals GMP Trend
The GMP chart and history table above let you watch how unofficial demand has evolved through the bidding window. A few things worth noting when interpreting this data:
- Stable or rising GMP through bidding typically signals genuine investor demand and improves the odds of a positive listing day.
- A late-stage GMP spike (sudden jump only on the last day) is often speculative and tends to fade after listing — treat with caution.
- A declining GMP can signal either weakening sentiment or rational profit-booking by grey market players ahead of listing.
- GMP near zero or negative is a red flag — historically, IPOs that listed flat or in discount had GMP fizzle in the final days of bidding.
GMP Reliability for SME IPOs
SME IPO GMP is significantly more volatile than Mainboard GMP. Lower trading volume in the SME grey market and the smaller pool of dealers mean prices can swing sharply on small trades. Use SME GMP as a directional indicator rather than a precise price forecast — the actual listing price can deviate substantially from the implied GMP-based estimate, both upward and downward.
Avience Biomedicals IPO is expected to list on June 25, 2026. GMP signals between now and listing day are most useful as a real-time read on demand — final listing performance will also depend on subscription levels (especially QIB participation), fundamentals, and overall market conditions on the listing day.
For broader context on how GMP works as an indicator, see our explainer: What is IPO GMP?